Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Oncolytic Immunotherapy Using Chimeric HSV C134: A Phase I Trial and Establishment of Response Indicators in Recurrent Glioma Patients
Grant
Overview
Affiliation
Overview
Awarded By
National Cancer Institute/NIH/DHHS
Total Award Amount
1680234.00
Direct Costs
1361656.00
Sponsor Award Id
R01CA222903
Affiliation
Contributor
C. Ryan Miller
Investigator
Caitlin Dalgo MSN, BSN, RN
Investigator
Gary Cutter
Investigator
George Gillespie
Investigator
Inmaculada Aban
Investigator
Jacob Lepard
Investigator
James Markert M.D., M.P.H.
Principal Investigator
Jianmei Leavenworth Ph.D.
Investigator
Louis Nabors M.D.
Investigator
Philip Schmalz
Investigator